Ex Parte WilkinsonDownload PDFPatent Trial and Appeal BoardDec 31, 201211262544 (P.T.A.B. Dec. 31, 2012) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ Ex parte LAURA WILKINSON ____________ Appeal 2010-010815 Application 11/262,544 Technology Center 3700 ____________ Before MICHAEL C. ASTORINO, MICHAEL L. HOELTER, and RICHARD E. RICE, Administrative Patent Judges. RICE, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Laura Wilkinson (Appellant) seeks our review under 35 U.S.C. § 134 of the Examiner’s rejection of claims 1-21. An oral hearing was held December 10, 2012. We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM. Appeal 2010-010815 Application 11/262,544 2 The Claimed Subject Matter The claimed subject matter “relates to a label and labeling system for collection containers, and, more particularly, to a label with a fill line indicator and a labeling system with alignment indicia that may be color-coded.” Spec., para. [0001]. Claim 1, reproduced below, is representative of the subject matter on appeal: 1. A collection container comprising: a first label attached to a collection container, the first label comprising identification information, a first opaque portion, and a second opaque portion, the first opaque portion having an area that is smaller than an area of the second opaque portion, wherein the first label comprises a gap defined by a break between the first opaque portion and the second opaque portion, the gap indicating a desirable fill volume for the collection container. The Rejections The following Examiner’s rejections are before us for review: (1) claims 1, 2, 4-7 and 11 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Stevens (US 6,428,640 B1, iss. Aug. 6, 2002), Jensen (US 4,873,193, iss. Oct. 10, 1989), and Tussing (US 4,480,470, iss. Nov. 6, 1984); (2) claim 3 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Stevens, Jensen, Tussing and Weisbach (US 6,279,759 B1, iss. Aug. 28, 2001); Appeal 2010-010815 Application 11/262,544 3 (3) claims 8, 12, 13, 15, 16, 181 and 19-21 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Stevens, Jensen, Tussing and Hogan (US 6,209,921 B1, iss. Apr. 3, 2001); (4) claim 9 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Stevens, Jensen, Tussing and Levy (US 6,030,582, iss. Feb. 29, 2000); (5) claim 10 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Stevens, Jensen, Tussing and Yamazaki (US 5,061,263, iss. Oct. 29, 1991); and (6) claims 14 and 17 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Stevens, Jensen, Tussing and Falla (US 4,122,947, iss. Oct. 31, 1978). Rejection (1) − Claims 1, 2, 4-7 and 11 Appellant argues these claims as a group. App. Br. 10-16. We select claim 1 as representative. See 37 C.F.R. § 41.37(c)(1)(vii) (2011). The Examiner finds that Stevens discloses the recited features of claim 1 except an opaque section including first and second opaque portions, the first opaque portion having an area that is smaller than an area of the second opaque portion, wherein the opaque section comprises a gap defined by a break in the opaque section between the first opaque portion and the second opaque portion, the gap indicating a desirable fill volume for the collection container. Ans. 4. To remedy this deficiency in Stevens, the Examiner first turns to Jensen. The Examiner finds that Jensen discloses 1 Although claim 18 is not listed in the statement of the rejection on page 7 of the Answer, the Examiner discusses the rejection of claim 18 together with claims 15 and 16 on pages 11 to 14 of the Answer. Accordingly, we treat the failure to list claim 18 in the statement of the rejection on page 7 of the Answer as a typographical error. Appeal 2010-010815 Application 11/262,544 4 measurement indicia (specimen level markers 56 “spaced to define a desired fill volume, at an extreme most edge of the label”) and concludes that “it would have been obvious to a person having ordinary skill in the art at the time the invention was made to provide the level markings on an edge of the vial label of Stevens in order to allow an individual to determine desired level area for the specimen in a particular vial.” Id. at 5 (citing Jensen, col. 5, ll. 5-13, figs. 2, 3 and 4). Next, the Examiner turns to Tussing. The Examiner finds that Tussing discloses a measurement scale 36 having continuous indicia with gaps indicating certain fill volumes; the Examiner particularly points to “a first portion (Figure 2, Item 36 and small line under gap and numeral ‘4’) and a second portion (Figure 2, Item 36 and line over gap and numeral ‘4’ . . . ).” Ans. 5-6. The Examiner concludes that: it would have been obvious to a person having ordinary skill in the art at the time the invention was made to provide the label of Stevens modified by Jensen with measuring indicia in the manner as taught in Tussing in order to provide a label with the ability to indicate different levels within a desired fill range. Id. at 6. Appellant’s first argument is that “[t]he Tussing patent merely discloses a conventional clear, graduated cylinder coupled to a gas cap for measuring gas or oil,” does not teach or suggest “using a label of any kind for any purpose” and accordingly “is in a different field of endeavor than the present invention.” App. Br. 11-12; see also Reply Br. 4-5. This argument is not persuasive. First, in arguing that the Tussing patent merely discloses a conventional clear, graduated cylinder coupled to a gas cap for measuring gas or oil, Appellant fails to adequately explain how the Examiner erred in relying on measurement scale 36 of Tussing as disclosing continuous fill indicia with gaps indicating certain fill volumes. Second, even if Tussing is Appeal 2010-010815 Application 11/262,544 5 in a different field of endeavor than the invention, Tussing is not nonanalogous art if it is “is reasonably pertinent to the particular problem with which the inventor is involved.” In re Klein, 647 F.3d 1343, 1348 (Fed. Cir. 2011) (internal quotations omitted). Here, Appellant is involved with the problem of providing a quick, visual indication of the fill volume of a container.2 Tussing discloses an oil measurement scale 36 that provides a visual indication of the volume of oil in a cylinder 32. Tussing, col. 3, ll. 60- 63, figs. 1 and 2. We find that Tussing is reasonably pertinent to the problem of providing a quick, visual indication of the fill volume of a container, and that Tussing is not nonanalogous art for at least that reason. Appellant next argues that the combination of Stevens, Jensen and Tussing fail[s] to disclose or suggest a first label that includes a first opaque portion and a second opaque portion, with the first opaque portion having an area that is smaller than an area of the second opaque portion, and the first label including a gap defined by a break between the first opaque portion and the second opaque portion as required by independent claim 1. App. Br. 12. In support of this argument, Appellant contends that “a line, as shown by the measuring scale (36) in the Tussing patent, will not have an area because a line does not enclose a region” and [t]herefore, even if the small line shown under the numeral “4” in FIG. 2 [of Tussing] was considered to correspond to the first opaque portion and the longer line over the numeral “4” in FIG. 2 [of Tussing] was considered to correspond to the second opaque portion, the small line and the longer line of the Tussing 2 E.g., Spec., para. [0018] (“Opaque bar 33 with gap 35 provides a user of the container 10, such as a phlebotomist, with a quick, visual indication that the proper and intended amount of blood to be collected has been drawn and deposited in the container 10.”). Appeal 2010-010815 Application 11/262,544 6 patent do not have respective areas as required by independent claim 1. Id. However, we agree with the Examiner’s findings that the printed lines in Tussing’s figures have areas (Ans. 18) and that the breaks in the lines define clear gaps, even though numbers (indicative of volume) are in the gaps (id. at 19). Appellant further argues that “the gas cap of the Tussing patent cannot provide a gap for indicating a desirable fill volume for a collection container as recited by independent claim 1.” App. Br. 14 (referencing In re Gulack, 703 F.2d 1381 (Fed. Cir. 1983)). The Examiner’s position in response is that there is no difference in function between the indicia disclosed by the asserted combination of references and the indicia recited in claim 1, both of which “have fill volumes defined by gaps.” Ans. 18-19 (discussing Gulack).3 The Examiner further contends that a “desired fill volume” (emphasis added) is “just a method of use,” that the combination of references is “fully capable” of such use, and that “one can choose [his or her] desired fill volume based on the breaks between the opaque portions.” Id. at 19. Again, we agree with the Examiner. Appellant does not adequately explain why Tussing’s gap is incapable of indicating a desirable fill volume. See Reply Br. 8.4 3 An examiner must consider all claim limitations, including descriptive material, when determining patentability of an invention over the prior art. Gulack, 703 F.2d at 1385. However, the Examiner need not give patentable weight to descriptive material that does not have a new and unobvious functional relationship with the substrate. See Gulack, 703 F.2d at 1386; see also In re Ngai, 367 F.3d 1336, 1338 (Fed. Cir. 2004). 4 See, e.g., In re Schreiber, 128 F.3d 1473, 1477-78 (Fed. Cir. 1997) (claims directed to an apparatus must be distinguished from the prior art in terms of structure rather than function); see also In re Swinehart, 439 F.2d 210, 213 Appeal 2010-010815 Application 11/262,544 7 Finally, we are not persuaded by Appellant’s largely repetitive argument that the Examiner's conclusion of obviousness is based upon improper hindsight reasoning. Reply Br. 9-11. For the reasons discussed supra, we determine that the Examiner’s conclusion of obviousness is supported by adequate articulated reasoning with rational underpinning. Accordingly, we sustain the rejection of claims 1, 2, 4-7 and 11 under 35 U.S.C. § 103(a) as unpatentable over Stevens, Jensen and Tussing. Rejections (2) – Claim 3 Claim 3 depends from claim 1. Appellant argues with respect to the rejection of claim 3 that Weisbach does not cure the deficiencies in the rejection of claim 1 based on the combination of Stevens, Jensen and Tussing. App. Br. 17; Reply Br. 12. For the reasons discussed supra, there are no deficiencies to cure. Accordingly, we sustain the rejection of claim 3 under 35 U.S.C. § 103(a) as unpatentable over Stevens, Jensen, Tussing and Weisbach. Rejection (3) − Claims 8, 12, 13, 15, 16, 18 and 19-21 Claim 8 depends from claim 7, which in turn depends from claim 1. Appellant argues with respect to the rejection of claim 8 that Hogan does not cure the deficiencies in the rejection of claim 1 based on the combination of Stevens, Jensen and Tussing. App. Br. 18. For the reasons discussed supra, there are no deficiencies to cure and thus we sustain the rejection of claim 8 (CCPA 1971) (“[W]here the Patent Office has reason to believe that a functional limitation asserted to be critical for establishing novelty in the claimed subject matter may, in fact, be an inherent characteristic of the prior art, it possesses the authority to require the applicant to prove that the subject matter shown to be in the prior art does not possess the characteristic relied on.”). Appeal 2010-010815 Application 11/262,544 8 under 35 U.S.C. § 103(a) as unpatentable over Stevens, Jensen, Tussing and Hogan. Appellant argues that independent claims 12 and 15 are patentable for the same reasons as claim 1. Id. at 18-24; Reply Br. 4-11. For the reasons discussed supra in respect to the rejection of claim 1, we sustain the rejection of claims 12 and 15, and claims 13, 16, 18 and 19-21 dependent thereon,5 under 35 U.S.C. § 103(a) as unpatentable over Stevens, Jensen, Tussing and Hogan. Rejections (4)-(7) – Claims 9, 10, 14 and 17 Claims 9 and 10 each depend from claim 7, which in turn depends from claim 1. Claim 14 depends from claim 12. Claim 17 depends from claim 16, which in turn depends from claim 15. Appellant argues with respect to the rejections of claims 9, 10, 14 and 17 that Levy, Yamazaki and Falla do not cure the deficiencies in the rejection of claim 1 based on the combination of Stevens, Jensen and Tussing. App. Br. 24-26. For the reasons discussed supra, there are no deficiencies to cure and thus we sustain the rejections under 35 U.S.C. § 103(a) of: claim 9 as unpatentable over Stevens, Jensen, Tussing and Levy; claim 10 as unpatentable over Stevens, Jensen, Tussing and Yamazaki; and claims 14 and 17 as unpatentable over Stevens, Jensen, Tussing and Falla. DECISION We affirm the rejections of claims 1-21. No time period for taking any subsequent action in connection with 5 Separate patentability is not argued for dependent claims 13, 16, 18 and 19- 21. App. Br. 24; Reply Br. 11. Appeal 2010-010815 Application 11/262,544 9 this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(1)(iv). AFFIRMED mls Copy with citationCopy as parenthetical citation